Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (SHE:002223)
China flag China · Delayed Price · Currency is CNY
37.90
-0.70 (-1.81%)
Feb 13, 2026, 3:04 PM CST

SHE:002223 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
8,0407,5237,9197,0346,8316,666
Other Revenue
42.942.952.8167.7763.1859.94
8,0837,5667,9727,1026,8946,726
Revenue Growth (YoY)
10.17%-5.09%12.25%3.01%2.51%45.08%
Cost of Revenue
4,0343,7963,9163,7093,5863,189
Gross Profit
4,0483,7704,0553,3933,3083,537
Selling, General & Admin
2,1251,7901,4991,4521,3341,114
Research & Development
586.2546.68504.37496.4425.67401.52
Other Operating Expenses
-6.58-1.6932.9644.6731.9927.28
Operating Expenses
2,7172,3552,0272,0061,8181,528
Operating Income
1,3321,4152,0291,3871,4902,009
Interest Expense
-3.39-20.73-58.55-57.74-30.49-15.25
Interest & Investment Income
280.1261.13357.97185.19156.79153.1
Currency Exchange Gain (Loss)
19.6919.693.6699.33-0.04-138.06
Other Non Operating Income (Expenses)
-17.61-0.94-2.41-1.4-1.79-0.59
EBT Excluding Unusual Items
1,6101,6742,3291,6121,6142,008
Impairment of Goodwill
-22.39-22.39-40.95-77.43--29.66
Gain (Loss) on Sale of Investments
---4.112.162.17-0.32
Gain (Loss) on Sale of Assets
1.896.16555.26170.70.29-5.88
Asset Writedown
-5.76-2.56-13.66-1.99-0.86-0.12
Other Unusual Items
277.78277.7823.03136.6385.7546.72
Pretax Income
1,8621,9332,8491,8421,7022,019
Income Tax Expense
124.88128.56472.36269.73217.82262.04
Earnings From Continuing Operations
1,7371,8042,3761,5731,4841,757
Minority Interest in Earnings
3.021.4319.3822.35-1.62.45
Net Income
1,7401,8062,3961,5951,4821,759
Net Income to Common
1,7401,8062,3961,5951,4821,759
Net Income Growth
0.19%-24.63%50.21%7.60%-15.73%133.74%
Shares Outstanding (Basic)
9999989949919951,005
Shares Outstanding (Diluted)
9999989949919951,005
Shares Change (YoY)
0.28%0.35%0.35%-0.42%-1.02%0.18%
EPS (Basic)
1.741.812.411.611.491.75
EPS (Diluted)
1.741.812.411.611.491.75
EPS Growth
-0.09%-24.90%49.69%8.05%-14.86%133.33%
Free Cash Flow
1,7711,6881,9941,926916.882,152
Free Cash Flow Per Share
1.771.692.011.940.922.14
Dividend Per Share
0.8000.8000.8000.6000.3000.300
Dividend Growth
-33.33%-33.33%100.00%--25.00%
Gross Margin
50.09%49.83%50.87%47.77%47.99%52.59%
Operating Margin
16.48%18.70%25.45%19.53%21.61%29.87%
Profit Margin
21.53%23.87%30.05%22.46%21.50%26.15%
Free Cash Flow Margin
21.91%22.31%25.02%27.11%13.30%32.00%
EBITDA
1,5451,6252,2361,5861,6772,170
EBITDA Margin
19.12%21.48%28.04%22.33%24.33%32.26%
D&A For EBITDA
213.39210.62206.92199.14187.27161.02
EBIT
1,3321,4152,0291,3871,4902,009
EBIT Margin
16.48%18.70%25.45%19.53%21.61%29.87%
Effective Tax Rate
6.71%6.65%16.58%14.64%12.80%12.98%
Revenue as Reported
8,0837,5667,9727,1026,8946,726
Advertising Expenses
-171.34121.54147.18--
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.